Lupin Pharmaceuticals discontinued some quinapril tablets and recalled others in late December 2022, according to the American Society of Health-System Pharmacists. Pfizer and Solco Healthcare U.S. have their quinapril products on back order and allocation, respectively, and neither could estimate a resupply date.
Pfizer also reported a recall last April for 11 lots of its quinapril oral tablets, marketed as Accupril, but the drugmaker’s current shortage is because of a manufacturing delay, according to the ASHP.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
